Today’s Best Market Rumors (6/21/2012) J&J Risperdal Settlement

Print Email

Updated throughout the day on the 24/7 Wall St. Wire

Johnson & Johnson (NYSE: JNJ) is close to a deal with the government for off-label promotion of antipsychotic Risperdal (WSJ)

JPMorgan (NYSE: JPM) has sold most of its position in the credit derivatives index which lost it $2 billion (FT)

Douglas A. McIntyre

RSS Facebook Twitter